It is a hemostatic gel for temporary external use that’s designed to control moderate to severe bleeding. It is made by Cresilon in Brooklyn, New York. “Flowable as a gel, which means it gets ...

A biotechnology firm in the United States has received the Food and Drug Administration (FDA) clearance for its new innovation – a hemostatic gel that is designed to control moderate to severe ...

In emergencies, controlling the blood loss from a wound can be critical. Joe Landolina of Cresilon shares the progress being made with hemostatic gel that can stop the bleeding in seconds rather than ...